195 related articles for article (PubMed ID: 19075885)
1. Liposomal drug delivery: recent patents and emerging opportunities.
Webb MS; Rebstein P; Lamson W; Bally MB
Recent Pat Drug Deliv Formul; 2007; 1(3):185-94. PubMed ID: 19075885
[TBL] [Abstract][Full Text] [Related]
2. Liposome-based drug delivery of various anticancer agents of synthetic and natural product origin: a patent overview.
Akhtar N; Mohammed SA; Singh V; Abdellatif AA; Mohammad HA; Ahad A; Yusuf M; Khadri H; Naz M; Khan O; Rashid M; Khan RA
Pharm Pat Anal; 2020 May; 9(3):87-116. PubMed ID: 32609057
[TBL] [Abstract][Full Text] [Related]
3. Patenting of nanopharmaceuticals in drug delivery: no small issue.
du Toit LC; Pillay V; Choonara YE; Pillay S; Harilall SL
Recent Pat Drug Deliv Formul; 2007; 1(2):131-42. PubMed ID: 19075880
[TBL] [Abstract][Full Text] [Related]
4. Recent advances and patents on solid lipid nanoparticles.
Sawant KK; Dodiya SS
Recent Pat Drug Deliv Formul; 2008; 2(2):120-35. PubMed ID: 19075903
[TBL] [Abstract][Full Text] [Related]
5. Nanosuspensions in drug delivery: recent advances, patent scenarios, and commercialization aspects.
Chavhan SS; Petkar KC; Sawant KK
Crit Rev Ther Drug Carrier Syst; 2011; 28(5):447-88. PubMed ID: 22077201
[TBL] [Abstract][Full Text] [Related]
6. [Trends in the development of research in the field of liposomes (review of patent literature)].
Nesytova NIu; Paleva NS; Il'ina EV; Shenk P; Bendas F; Nun P
Vestn Akad Med Nauk SSSR; 1990; (6):8-19. PubMed ID: 2220043
[TBL] [Abstract][Full Text] [Related]
7. Recent Patents, Formulation and Characterization of Nanoliposomes.
Rohilla S; Dureja H
Recent Pat Drug Deliv Formul; 2015; 9(3):213-24. PubMed ID: 26118425
[TBL] [Abstract][Full Text] [Related]
8. Nanostructured Systems in Advanced Drug Targeting for the Cancer Treatment: Recent Patents.
Anaya-Ruiz M; Bandala C; Landeta G; Martínez-Morales P; Zumaquero-Rios JL; Sarracent-Pérez J; Pérez-Santos M
Recent Pat Anticancer Drug Discov; 2019; 14(1):85-94. PubMed ID: 30381087
[TBL] [Abstract][Full Text] [Related]
9. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
10. Liposomal drug delivery systems: an update review.
Samad A; Sultana Y; Aqil M
Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
[TBL] [Abstract][Full Text] [Related]
11. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential.
Immordino ML; Dosio F; Cattel L
Int J Nanomedicine; 2006; 1(3):297-315. PubMed ID: 17717971
[TBL] [Abstract][Full Text] [Related]
12. Recent patents review in microencapsulation of pharmaceuticals using the emulsion solvent removal methods.
Obeidat WM
Recent Pat Drug Deliv Formul; 2009 Nov; 3(3):178-92. PubMed ID: 19925442
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in therapeutics and drug delivery for the treatment of inner ear diseases: a patent review (2011-2015).
Nguyen K; Kempfle JS; Jung DH; McKenna CE
Expert Opin Ther Pat; 2017 Feb; 27(2):191-202. PubMed ID: 27855527
[TBL] [Abstract][Full Text] [Related]
14. Exploration of Global Trend on Biomedical Application of Polyhydroxyalkanoate (PHA): A Patent Survey.
Paulraj P; Vnootheni N; Chandramohan M; Thevarkattil MJP
Recent Pat Biotechnol; 2018; 12(3):186-199. PubMed ID: 29384069
[TBL] [Abstract][Full Text] [Related]
15. Recent Patents, Formulation Techniques, Classification and Characterization of Liposomes.
Sheoran R; Khokra SL; Chawla V; Dureja H
Recent Pat Nanotechnol; 2019; 13(1):17-27. PubMed ID: 30479223
[TBL] [Abstract][Full Text] [Related]
16. Liposomal formulation for dermal and transdermal drug delivery: past, present and future.
Nounou MI; El-Khordagui LK; Khalafallah NA; Khalil SA
Recent Pat Drug Deliv Formul; 2008; 2(1):9-18. PubMed ID: 19075893
[TBL] [Abstract][Full Text] [Related]
17. Pelletization processes for pharmaceutical applications: a patent review.
Politis SN; Rekkas DM
Recent Pat Drug Deliv Formul; 2011 Jan; 5(1):61-78. PubMed ID: 21143125
[TBL] [Abstract][Full Text] [Related]
18. ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524.
Drugs R D; 2007; 8(2):103-12. PubMed ID: 17324008
[TBL] [Abstract][Full Text] [Related]
19. Microemulsions: a novel approach to enhanced drug delivery.
Talegaonkar S; Azeem A; Ahmad FJ; Khar RK; Pathan SA; Khan ZI
Recent Pat Drug Deliv Formul; 2008; 2(3):238-57. PubMed ID: 19075911
[TBL] [Abstract][Full Text] [Related]
20. Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
Drugs R D; 2005; 6(3):178-85. PubMed ID: 15869322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
